Large Pore-Sized Hollow Mesoporous Organosilica for Redox-Responsive Gene Delivery and Synergistic Cancer Chemotherapy

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 28(2016), 10 vom: 09. März, Seite 1963-9
1. Verfasser: Wu, Meiying (VerfasserIn)
Weitere Verfasser: Meng, Qingshuo, Chen, Yu, Zhang, Lingxia, Li, Mengli, Cai, Xiaojun, Li, Yaping, Yu, Pengcheng, Zhang, Linlin, Shi, Jianlin
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't cancer therapy gene delivery large pores multidrug resistance nanoparticles Alloys Antineoplastic Agents Drug Carriers mehr... Metals Oxides Silicon Dioxide 7631-86-9
LEADER 01000naa a22002652 4500
001 NLM256247609
003 DE-627
005 20231224180225.0
007 cr uuu---uuuuu
008 231224s2016 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.201505524  |2 doi 
028 5 2 |a pubmed24n0854.xml 
035 |a (DE-627)NLM256247609 
035 |a (NLM)26743228 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Wu, Meiying  |e verfasserin  |4 aut 
245 1 0 |a Large Pore-Sized Hollow Mesoporous Organosilica for Redox-Responsive Gene Delivery and Synergistic Cancer Chemotherapy 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 13.12.2016 
500 |a Date Revised 18.03.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
520 |a A stability-difference-selective bond-breakage strategy for the fabrication of largepore-sized hollow mesoporous organosilica nanoparticles (HMONs) is successfully developed. Moreover, surfacefunctionalized HMONs are successfully constructed to simultaneously deliver P-gp modulator siRNA and anticancer drug doxorubicin to reverse the multidrug resistance of cancer cells 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a cancer therapy 
650 4 |a gene delivery 
650 4 |a large pores 
650 4 |a multidrug resistance 
650 4 |a nanoparticles 
650 7 |a Alloys  |2 NLM 
650 7 |a Antineoplastic Agents  |2 NLM 
650 7 |a Drug Carriers  |2 NLM 
650 7 |a Metals  |2 NLM 
650 7 |a Oxides  |2 NLM 
650 7 |a Silicon Dioxide  |2 NLM 
650 7 |a 7631-86-9  |2 NLM 
700 1 |a Meng, Qingshuo  |e verfasserin  |4 aut 
700 1 |a Chen, Yu  |e verfasserin  |4 aut 
700 1 |a Zhang, Lingxia  |e verfasserin  |4 aut 
700 1 |a Li, Mengli  |e verfasserin  |4 aut 
700 1 |a Cai, Xiaojun  |e verfasserin  |4 aut 
700 1 |a Li, Yaping  |e verfasserin  |4 aut 
700 1 |a Yu, Pengcheng  |e verfasserin  |4 aut 
700 1 |a Zhang, Linlin  |e verfasserin  |4 aut 
700 1 |a Shi, Jianlin  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 28(2016), 10 vom: 09. März, Seite 1963-9  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:28  |g year:2016  |g number:10  |g day:09  |g month:03  |g pages:1963-9 
856 4 0 |u http://dx.doi.org/10.1002/adma.201505524  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 28  |j 2016  |e 10  |b 09  |c 03  |h 1963-9